[1]Le Bousse-Kerdilès M, Marié-Claire M, Samson M.Cel-lular and molecular mechanisms underlying bone marrow andliver fibrosis:a review[J].Eur cytokine netw, 2008, 19 (2) :69-80.
|
[2] Wynn TA.Cellular and molecular mechanisms of fibrosis[J]. J pathology, 2008, 214 (2) : 199-210.
|
[3] Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis[J]. Apoptosis, 2005, 10 (5) : 927-939.
|
[4]Li K.Mechanism of curcumine on the suppression of the ex-pression of TGF beta 1 and CTGF signaling pathway on ex-perimental hepatic fibrosis[J].Int J Infect Dis, 2010, 14:39-39.
|
[5] OoYH, Shetty S, Adams DH. The Role of chemokines in the recruitment of lymphocytes to the liver[J]. Dig Dis, 2010, 34 (1) : 45-54.
|
[6]Braz MM, Ramalho FS, Cardoso RL, et al.Slight activationof nuclear factor kappa-B is associated with increased he-patic stellate cell apoptosis in human schistosomal fibrosis[J].Acta Trop, 2010, 113 (1) :66-71.
|
[7]Guicciardi ME, Gores GJ.Apoptosis as a Mechanism for Liv-er Disease Progression[J].Semin Liver Dis, 2010, 30 (4) :402-410.
|
[8]Qin L, Han Y.Epigenetic Repression of Matrix Metalloprotei-nases in Myofibroblastic Hepatic Stellate Cells through His-tone Deacetylases 4 Implication in Tissue Fibrosis[J].Am JPathol, 2010, 177 (4) :1915-1928.
|
[9]Czaja MJ.The future of GI and liver research:editorial per-spectives.Ⅲ.JNK/AP-1 regulation of hepatocyte death[J].Am J Physiol Gastrointest Liver Physiol, 2003, 284 (6) :G875-879.
|
[1] | Wang HongSha, Wei Qi, Lei ManMan, Jin QingLong, Wen XiaoYu, Guo YuYing. Acute hepatitis B complicated by EB virus infection: a case report[J]. Journal of Clinical Hepatology, 2017, 33(4): 725-727. doi: 10.3969/j.issn.1001-5256.2017.04.026 |
[2] | Zhu Peng, Tang Yi, Wang YuMing. Recommendations for APASL Clinical Practice Guidelines: management of hepatitis B (updated in 2015)[J]. Journal of Clinical Hepatology, 2016, 32(3): 423-428. doi: 10.3969/j.issn.1001-5256.2016.03.004 |
[3] | Li Jun. Clinical research progress in integrated traditional Chinese and Western medicine therapy for HBV-related liver failure[J]. Journal of Clinical Hepatology, 2015, 31(1): 42-47. doi: 10.3969/j.issn.1001-5256.2015.01.010 |
[4] | Sun YuMei, Zhou YingXia, Xing HuiChun, Lin KeKe. Clock drawing test in cognitive assessment for patients with hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 413-417. doi: 10.3969/j.issn.1001-5256.2015.03.024 |
[5] | Xu Ying, Liu Yu, Sun Jian. Key points of the AASLD′s guidelines on hepatitis B diagnosis and treatment[J]. Journal of Clinical Hepatology, 2013, 29(2): 162-169. |
[6] | Yan Tao, Li Fan, Li Ke, Zhao Ping, Wang HuiFen. Analysis of mutational patterns of the pre-C/C region of with hepatitis B virus in patients with HBV-associated acute-on-chronic liver failure [J]. Journal of Clinical Hepatology, 2013, 29(2): 120-123+127. |
[7] | Jiang LiSheng, Li YongGuo, Chen Shu, Lan YingHua. Short-term and long-term efficacy of antiviral treatment of patients with HBV-associated acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2013, 29(2): 110-113. |
[8] | Cao Xiao, Cao QingBao, Zhang GuoQiang, Chang ZaiJuan, Li ShuPing, Xu WeiWei. Analysis of occult hepatitis B virus infection among blood donors in Tangshan, China[J]. Journal of Clinical Hepatology, 2013, 29(2): 117-119. |
[9] | Zhang Tao, Sun KeWei. Experience and progresses of Chinese medicine therapy for hepatitis B-associated liver failure[J]. Journal of Clinical Hepatology, 2012, 28(3): 169-171+182. |
[10] | Peng JianPing, Sun KeWei, Wu YuNan. Impact of early virological response to antiviral treatment on the outcomes of hepatitis B-associated liver failure [J]. Journal of Clinical Hepatology, 2012, 28(10): 752-755. |
[11] | Wang XiaoJing, Ning Qin. Prospect and progression on severe acute exacerbation of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2012, 28(6): 401-404+412. |
[12] | Hu XiaoLi, Zhao HongWei, Wu XiaoYan, Niu JunQi. Prevalence of hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2012, 28(6): 413-416+421. |
[13] | Deng Le, Wen ZhiLi. Review of recent research progress in correlating HBV genotypes with efficacy of antiviral treatments[J]. Journal of Clinical Hepatology, 2012, 28(6): 469-473. |
[14] | Gao Zhen, Zhang LunLi. Toll like receptors mediated innate immune responses against HBV infection[J]. Journal of Clinical Hepatology, 2011, 27(6): 667-669+673. |
[15] | Yuan JianGuo, Wang XinGuo, Cui Xia, Liu FengHua, Wang FengHua, Song JiKui, Zhao HongKui. The activation of rat hepatic stellate cells stimulated with hepatitis B virus in vitro[J]. Journal of Clinical Hepatology, 2011, 27(2): 163-165. |
[16] | Zhao YanJuan, Ye ChunYan, Song XiaoDan. The change in serum thyroid hormone levels in acute hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(2): 161-162+165. |
[17] | Gu MaoLin, Wang XingLiang, Wu TingTing. Detection of HBV-LP and relationships between HBV DNA and its level in HBV patients with different patterns of HBV Markers[J]. Journal of Clinical Hepatology, 2011, 27(8): 810-812. |
[18] | Yu Hui. Advances in epidemiology, diagnosis and treatment of hepatitis B in children[J]. Journal of Clinical Hepatology, 2011, 27(7): 687-689. |
[19] | Liu Li, Hu XiaoXuan. A report of severe hepatitis with wilson desease and hepatitis B[J]. Journal of Clinical Hepatology, 2010, 26(6): 657+66. |
[20] | Shi YanMei, Lan YingHua, Dan Lei, Zhou Jin, Li YongGuo. The relationship between of hematopoietic stem cells and hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2010, 26(4): 377-380. |